Cresco Labs Inc.
Qualité des données : 100%
CRLBF
OTC
Manufacturing
Chemicals
0,93 €
▼
0,02 €
(-2,34%)
Cap. Boursière: 345,87 M
Prix
0,96 €
Cap. Boursière
345,87 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Generating 37,75 M in free cash flow
Capital efficient — spends only 5,36% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-9,46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-33,22%
Au-dessus de la moyenne du secteur (-53,34%)
ROIC-1,86%
Net Margin-20,65%
Op. Margin-4,27%
Sécurité
Debt / Equity
1,26
Au-dessus de la moyenne du secteur (0,31)
Current Ratio2,59
Interest Coverage-0,67
Valorisation
PE (TTM)
-2,55
En dessous de la moyenne du secteur (-1,47)
P/B Ratio1,02
EV/EBITDA34,54
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -2,6 | -1,5 |
| P/B | 1,0 | 1,6 |
| ROE % | -33,2 | -53,3 |
| Net Margin % | -20,7 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | 1,3 | 0,3 |
Objectif de Cours des Analystes
1 analyste
Buy
Actuel
0,93 €
Objectif
2,00 €
2,00 €
2,00 €
2,00 €
Prévisions
P/E Prévisionnel
-8,43
BPA Prévisionnel
-0,11 €
CA Est.
651,84 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
-0,11 €
-0,11 € – -0,11 €
|
651,84 M | 1 |
| FY2026 |
-0,10 €
-0,10 € – -0,10 €
|
620,75 M | 1 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
-0,03 €
-0,04 € – -0,02 €
|
152,82 M | 3 |
| 2026 Q1 |
-0,04 €
-0,04 € – -0,03 €
|
148,88 M | 3 |
Surprises de Résultats
Derniers 4 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | -0,03 € | N/A | — |
| Q32025 | -0,04 € | 0,01 € | +120,4% |
| Q22025 | -0,04 € | -0,02 € | +51,6% |
| Q12025 | -0,03 € | 0,02 € | +187,0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -9,46% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 655,85 M | Net Income (TTM) | -135,41 M |
| ROE | -33,22% | ROA | -10,61% |
| Gross Margin | 49,49% | Operating Margin | -4,27% |
| Net Margin | -20,65% | Free Cash Flow (TTM) | 37,75 M |
| ROIC | -1,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,26 | Current Ratio | 2,59 |
| Interest Coverage | -0,67 | Asset Turnover | 0,51 |
| Working Capital | 159,09 M | Tangible Book Value | -143,07 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,55 | Forward P/E | N/A |
| P/B Ratio | 1,02 | P/S Ratio | 0,53 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 34,54 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 10,92% | ||
| Market Cap | 345,87 M | Enterprise Value | 715,85 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,38 | Revenue / Share | 1,82 |
| FCF / Share | 0,11 | OCF / Share | 0,20 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 5,36% | FCF Conversion | -27,88% |
| SBC-Adj. FCF | 26,52 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 655,85 M | 724,34 M |
| Net Income | -135,41 M | -74,44 M |
| EPS (Diluted) | -0,38 | -0,22 |
| Gross Profit | 324,57 M | 364,45 M |
| Operating Income | -27,99 M | 107,29 M |
| EBITDA | — | — |
| R&D Expenses | — | — |
| SG&A Expenses | 247,45 M | 254,84 M |
| D&A | 48,71 M | 59,10 M |
| Interest Expense | 41,75 M | 37,93 M |
| Income Tax | 44,62 M | 49,87 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 1,20 B | 1,36 B |
| Total Liabilities | 944,80 M | 967,18 M |
| Shareholders' Equity | 340,45 M | 474,85 M |
| Total Debt | 427,88 M | 472,68 M |
| Cash & Equivalents | 57,90 M | 137,56 M |
| Current Assets | 259,27 M | 294,26 M |
| Current Liabilities | 100,18 M | 94,34 M |
{"event":"ticker_viewed","properties":{"ticker":"CRLBF","listing_kind":"stock","pathname":"/stocks/crlbf","exchange":"OTC","country":"US"}}